Review of psychodynamic psychotherapy neuroimaging studies

Psychotherapy and Psychosomatics

Volumn 83, Issue 3, 2014, Pages 142-147

  Abbass, Allan A ^a   Nowoweiski, Sarah J ^c   Bernier, Denise ^a   Tarzwell, Robert ^b   Beutel, Manfred E ^d  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Melbourne Centre for ISTDP   (Australia)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Anxiety; Brain imaging; Depression; Functional magnetic resonance imaging; Neural correlates; Positron emission tomography; Psychodynamic psychotherapy; Single photon emission computed tomography

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FLUOXETINE; SEROTONIN 1A RECEPTOR; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORTER; DOPAMINE TRANSPORTER; SEROTONIN TRANSPORTER;

ANTERIOR CINGULATE; ANTIDEPRESSANT ACTIVITY; BORDERLINE STATE; BRAIN FUNCTION; BRAIN REGION; DATA BASE; DISEASE SEVERITY; DYSTHYMIA; EMOTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; HYPOMANIA; MAJOR DEPRESSION; MOOD DISORDER; NEUROIMAGING; PANIC; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHODYNAMIC PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOCIAL ADAPTATION; SOMATOFORM DISORDER; SYNAPTIC TRANSMISSION; THALAMUS; TREATMENT DURATION; TREATMENT RESPONSE; BRAIN; MENTAL DISORDERS; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME; AMYGDALOID NUCLEUS; ARTICLE; ATYPICAL DEPRESSION; CASE STUDY; DEPRESSION; HIPPOCAMPUS; LIMBIC SYSTEM; MESENCEPHALON; NEUROTRANSMISSION; OCCIPITAL CORTEX; PARAHIPPOCAMPAL GYRUS; POSITRON EMISSION TOMOGRAPHY; POSTCENTRAL GYRUS; POSTERIOR INSULA; RECEPTOR BINDING; SUPERIOR TEMPORAL GYRUS; SYSTEMATIC REVIEW; TEMPORAL LOBE;

BRAIN; FUNCTIONAL NEUROIMAGING; HUMANS; MENTAL DISORDERS; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORT PROTEINS; PSYCHOTHERAPY, PSYCHODYNAMIC; RECEPTOR, SEROTONIN, 5-HT1A; TREATMENT OUTCOME;

EID: 84897967131     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000358841     Document Type: Review

References (33)

1. Shedler J: The efficacy of psychodynamic psychotherapy. Am Psychol 2010; 65:98-109.
2. Abbass A, Kisely S, Kroenke K: Short-term psychodynamic psychotherapy for somatic disorders: systematic review and meta-analy-sis of clinical trials. Psychother Psychosom 2009; 78:265-274.
3. Town JM, Abbass A, Hardy G: Short-term psychodynamic psychotherapy for personality disorders: a critical review of randomized controlled trials. J Pers Disord 2011; 25:723-740.
4. Leichsenring F, Rabung S: Effectiveness of long-term psychodynamic psychotherapy: a meta-analysis. JAMA 2008; 300: 1551-1565.
5. Quidé Y, Witteveen AB, El-Hage W, Velt-man DJ, Olff M: Differences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: a systematic review. Neurosci Biobehav Rev 2012; 36: 626-644.
6. Sözeri-Varma G, Karadag F: The biological effects of psychotherapy in major depressive disorders: a review of neuroimaging studies. Psychology 2012; 3:857-863.
7. Fitzgerald PB, Laird AR, Maller J, Daskalakis ZJ: A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp 2008; 29:683-695.
8. Nikolaus S, Antke C, Müller HW: In vivo imaging of synaptic function in the central nervous system. II. Mental and affective disorders. Behav Brain Res 2009; 204: 32-66.
9. Nikolaus S, Antke C, Beu M, Müller HW: Cortical GABA, striatal dopamine and mid-brain serotonin as the key players in compulsive and anxiety disorders: results from in vivo imaging studies. Rev Neurosci 2010; 21: 119-139.
10. Roffman JL, Gerber AJ, Glick DM: Neural models of psychodynamic concepts and treatments: implications for psychodynamic psychotherapy; in Levy RA, Ablon JS, Kachele H (eds): Psychodynamic Psychotherapy Research: Evidence-Based Practice and Practice-Based Evidence. New York, Springer, 2012, pp 193-218.
11. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group: Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. BMJ 2009; 339:b2535.
12. 11C]raclo-pride PET. J Psychopharmacol 2011; 25:1329-1336.
13. Lehto SM, Tolmunen T, Joensuu M, Saarinen PI, Valkonen-Korhonen M, Vanninen R, Ahola P, Tiihonen J, Kuikka J, Lehtonen J: Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy. Prog Neuro-psychopharmacol Biol Psychiatry 2008; 32: 229-237.
14. Buchheim A, Viviani R, Kessler H, Kächele H, Cierpka M, Roth G, George C, Kernberg OF, Bruns G, Taubner S: Changes in prefrontal-limbic function in major depression after 15 months of long-term psychotherapy. PLoS One 2012; 7:e33745.
15. Beutel ME, Stark R, Pan H, Silbersweig D, Dietrich S: Changes of brain activation pre-post short-term psychodynamic inpatient psychotherapy: an fMRI study of panic disorder patients. Psychiatry Res 2010; 184:96-104.
16. Lai C, Daini S, Calcagni ML, Bruno I, de Risio S: Neural correlates of psychodynamic psychotherapy in borderline disorders: a pilot investigation. Psychother Psychosom 2007; 76: 403-405.
17. Saarinen PI, Lehtonen J, Joensuu M, Tol-munen T, Ahola P, Vanninen R, Kuikka J, Ti-ihonen J: An outcome of psychodynamic psychotherapy: a case study of the change in serotonin transporter binding and the activation of the dream screen. Am J Psychother 2005; 59:61-73.
18. Tolmunen T, Joensuu M, Saarinen PI, Mus-salo H, Ahola P, Vanninen R, Kuikka J, Tiiho-nen J, Lehtonen J: Elevated midbrain serotonin transporter availability in mixed mania: a case report. BMC Psychiatry 2004; 4:27.
19. Viinamaki H, Kuikka J, Tiihonen J, Lehtonen J: Change in monoamine transporter density related to clinical recovery: a case-control study. Nord J Psychiatry 1998; 52:39-44.
20. 1A receptors in patients with major depressive disorder. Psychol Med 2010; 40:523-528.
21. de Greck M, Scheidt L, Bölter AF, Frommer J, Ulrich C, Stockum E, Enzi B, Tempelmann C, Hoffmann T, Northoff G: Multimodal psy-chodynamic psychotherapy induces normalization of reward related activity in somato-form disorder. World J Biol Psychiatry 2011; 12:296-308.
22. de Greck M, Bölter AF, Lehmann L, Ulrich C, Stockum E, Enzi B, Hoffmann T, Tempel-mann C, Beutel M, Frommer J, Northoff G: Changes in brain activity of somatoform disorder patients during emotional empathy after multimodal psychodynamic psychotherapy. Front Hum Neurosci 2013; 7:410.
23. Eldaief M, Dougherty D: Advances in neuro-imaging: impact on psychiatric practice. Psychiatric Times, October 2008.
24. Karlsson H, Hirvonen J, Salminen J, Hietala J: Increased serotonin receptor 1A binding in major depressive disorder after psychotherapy, but not after SSRI pharmacotherapy, is related to improved social functioning capacity. Psychother Psychosom 2013; 82:260-261.
25. Boeker H, Richter A, Himmighoffen H, Ernst J, Bohleber L, Hofmann E, Vetter J, Northoff G: Essentials of psychoanalytic process and change: how can we investigate the neural effects of psychodynamic psychotherapy in individualized neuro-imaging? Front Hum Neurosci 2013; 7:355.
26. Green S, Lambon Ralph MA, Moll J, Deakin JF, Zahn R: Guilt-selective functional disconnection of anterior temporal and subgenual cortices in major depressive disorder. Arch Gen Psychiatry 2012; 69:1014-1021.
27. Takeuchi H, Taki Y, Nouchi R, Hashizume H, Sekiguchi A, Kotozaki Y, Nakagawa S, Miyau-chi CM, Sassa Y, Kawashima R: Anatomical correlates of self-handicapping tendency. Cortex 2013; 49:1148-1154.
28. Schmeing JB, Kehyayan A, Kessler H, Do Lam AT, Fell J, Schmidt AC, Axmacher N: Can the neural basis of repression be studied in the MRI scanner? New insights from two free association paradigms. PLoS One 2013; 8:e62358.
29. Zantvoord JB, Diehle J, Lindauer RJ: Using neurobiological measures to predict and assess treatment outcome of psychotherapy in post-traumatic stress disorder: systematic review. Psychother Psychosom 2013; 82: 142-151.
30. Konarski JZ, Kennedy SH, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS: Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci 2009; 34:175-180.
31. Siegle GJ, Thompson WK, Collier A, Berman SR, Feldmiller J, Thase ME, Friedman ES: Toward clinically useful neuroimaging in depression treatment: prognostic utility of sub-genual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Arch Gen Psychiatry 2012; 69:913-924.
32. Blagys MD, Hilsenroth MJ: Distinctive activities of cognitive-behavioral therapy: a review of the comparative psychotherapy process literature. Clin Psychol Rev 2002; 22:671-706.
33. Ulvenes PG, Berggraf L, Hoffart A, Stiles TC, Svartberg M, McCullough L, Wampold BE: Different processes for different therapies: therapist actions, therapeutic bond, and outcome. Psychotherapy (Chic) 2012; 49: 291-302.